Research Article

Site-Specific Hypermethylation of SST 1stExon as a Biomarker for Predicting the Risk of Gastrointestinal Tract Cancers

Table 2

Correlation of methylation of SST and clinical phenotypes.

CancerParameterGroup182534424485929497100116127129138148AVG

ECLymphatic metastasisPositive250.4970.6540.710.3110.4050.8580.6170.7490.7980.2650.4050.8280.9690.4970.7880.513
Negative17
Vascular tumor emboliPositive90.7180.9760.7860.5870.4140.2490.5260.6510.3030.1710.3030.0210.0380.0750.0980.224
Negative33
Depth of infiltrationSerosa260.1410.4510.920.2010.2680.0410.4780.6680.0990.0350.0940.40.510.3160.3550.641
Muscular13
Mucosal and submucosal3
DifferentiationPoorly50.0140.170.150.3810.3810.8270.9370.8970.8030.9770.1950.2890.1430.2470.3460.289
Moderately21
High16

GCLymphatic metastasisPositive640.4710.0130.0730.2570.5780.3390.8210.8040.910.9580.5660.8690.8480.4870.3010.924
Negative27
Vascular tumor emboliPositive570.9610.9930.0850.6080.4260.3480.7240.9310.8790.5830.6880.7370.8310.70.4030.974
Negative34
Depth of infiltrationSerosa790.4720.6620.7430.5080.3470.0970.4850.6680.2840.5170.3090.4790.3630.2950.2650.356
Muscular9
Mucosal and submucosal3
DifferentiationPoorly750.6080.6580.8110.7250.6670.1190.7750.9910.5510.8840.4460.4990.4620.3490.3640.685
Moderately12
High4

CRCLymphatic metastasisPositive380.6580.560.9390.810.9230.7580.7210.9730.7580.6510.210.2720.3210.2850.060.63
Negative42
Vascular tumor emboliPositive110.9170.2730.7430.9390.9940.2270.5340.9050.850.9170.5530.660.6910.4630.7960.917
Negative69
Depth of infiltrationSerosa590.5810.8910.2670.1840.1020.90.130.0250.1840.0830.1190.0580.2530.2070.2270.173
Muscular21
Mucosal and submucosal0
DifferentiationPoorly250.760.360.530.2890.1510.5190.240.0810.3510.2710.4260.1390.4970.6470.3340.157
Moderately40
High15